Ignite Creation Date:
2024-05-06 @ 3:32 PM
Last Modification Date:
2024-10-26 @ 1:51 PM
Study NCT ID:
NCT04666649
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-04-08
First Post:
2020-12-07
Brief Title:
Pegcrisantaspase in Combination With Venetoclax for Treatment of Relapsed or Refractory Acute Myeloid Leukemia RR AML
Sponsor:
University of Maryland Baltimore
Organization:
University of Maryland Baltimore
Organization Data
Organization:
University of Maryland Baltimore
Class:
OTHER
Study ID:
2087GCCC HP-00093729
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Maryland Baltimore
Lead Sponsor Class:
OTHER
Responsible Party:
Vu Duong
Responsible Party Title:
Professor of Medicine and Pharmacology University of Maryland School of Medicine Associate Director for Clinical Research
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
University of Maryland Baltimore
Old Name:
None
Old Organization:
None